List view / Grid view
Following a successful pilot in 2021, Sanofi and McLaren Racing…
Following a successful pilot in 2021, Sanofi and McLaren Racing have decided to extend their collaboration across multiple sites in seven countries, covering more than 100 production lines, across all technologies.
Sanofi’s new Diversity, Equity & Inclusion (DE&I) Board, and accompanying…
Sanofi’s new Diversity, Equity & Inclusion (DE&I) Board, and accompanying global Employee Resource Group (ERG) framework, will support the delivery of the company’s DE&I strategy.
Sanofi is set to acquire Principia Biopharma Inc. for a…
Sanofi is set to acquire Principia Biopharma Inc. for a total aggregate equity value of $3.68 billion, at $100 per share.
Sanofi will provide its S protein antigen and GSK will…
Sanofi will provide its S protein antigen and GSK will contribute its adjuvant technology in a partnership to develop a COVID-19 vaccine.
Sanofi has announced it is to acquire Synthorx to bolster…
Sanofi has announced it is to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 billion.
